Witness the significant development of microbiome, probiotics and prebiotics research alongside their applications relating to difficulties like therapeutic information understanding, speculation and administrative obstacles looked by the experts. The convergence between developing innovation and disclosure with the setting of consumer intrigue. Recognize the non-distinguished dysbiosis, to find the expected territories under examination for interests in Gut and Skin microbiome and its part as an indicative instrument of drug revelation.
Connect with biotech, pharma, academicians and investors at 3rd Edition Next Gen Microbiome and Probiotics- Virtual Conference, February 2021 discussing the most ingenious research and technological advances. This online conference will hold discussions on the nutraceutical and consumer approaches along with Microbiome as a science and its clinical application. Key sessions on R&D to commercialization- how to effectively translate research into commercialization along with overcoming microbiome research and probiotics product development challenges.
Date: 25th – 26th of February 2021
Time: 10:30 – 16:30
Discount for MVA members:
- MVA Industry delegates can register for free with discount code MMMICRO100
- MVA Solutions providers can register with a 25 % discount with discount code MM-MVA25
- Microbial Innovations
- Gut and Skin Microbiota
- Regulatory Issues
- Pediatrics and infant health
- Live Probiotic Technology
- Strain Identification
- Fecal Microbiota & Engineered Microbiome
- Commercialization and R&D Collaborations
Who should attend?
Medical Directors, Principal Investigators, Methodologists, and other clinical research professionals from pharmaceuticals, nutraceuticals and therapeutics-based organizations from the departments of:
- Microbiome discovery
- Department of Biochemistry and Immunology
- Microbiome science
- Biological Science
- Gut Biology
- Human microbiome
- Drug discovery